Mike Hennessy Jr, Chairman and CEO

Drug shortages, such as the shortages of cisplatin and carboplatin in 2023, have significantly affected oncology.

As pharmacists continue to step into additional roles, culturally competent care becomes an even more essential part of their practices.

These developments highlight the dynamic landscape of health care innovation and the collaborative efforts driving progress in disease management and treatment.

The impact pharmacist-led research on oncology pharmacy practice in the field of oncology is undeniable.

Opill is a nonprescription, progestin-only contraceptive pill, with nearly 50 years of use and data supporting the safety and effectiveness of progestin-only pills.

Continuous glucose monitoring (CGM) is a valuable tool in managing diabetes, offering real-time data on glucose levels throughout the day.

"Pharmacy Practice in Focus: Oncology" welcomes the launch of the peer-review process.

2023 was an impactful year for the field of oncology pharmacy.

In 2024, Pharmacy Practice in Focus: Health Systems welcomes the launch of the peer-review process, with this issue containing our first peer-reviewed paper.

As HIV has become a manageable chronic condition, and even curable in some cases, the role of pharmacists cannot be understated.

Exclusions of medication are often focused on high-cost specialty formularies, resulting in fewer options for patients who need them.

With appointment-based models in community pharmacy, researchers have noted that community pharmacies are well suited for identifying and addressing social determinants of health.

The need for additional data on safety and efficacy of medicines both new and old that assess all potential risk factors is ever present, with health system pharmacists at the front lines.

Pharmacy schools have also been seeing a change not only in education about personalized patient care and community-centered care.

Artificial intelligence has helped ensure a data-driven methodology for evaluating eligibility criteria for clinical trials, facilitating more inclusive trial design.

October offers us a chance to take a step back to admire the hard work and dedication that pharmacists show day in and day out.

With back-to-school season already over and the fall rapidly approaching, health systems are bracing for another season of influenza, COVID-19, and respiratory syncytial virus.

As we approach November 27, 2024, new regulations and updates may arise for health system pharmacies to be aware of to remain compliant.

Although the price and availability timeline of norgestrel have yet to be determined, experts already agree that it is an important step toward increased access to contraception.

Renewed focus on the potential this drug can provide patients is upon us as we continue to strive for greater and better care and treatment for patients throughout US health systems.

The American Society of Clinical Oncology (ASCO) Annual Meeting includes updates from some of the most important clinical trials being conducted in the field of oncology.

The DEA’s decision allows some health care providers to have more leeway in prescribing certain controlled substances.

Key topics in May include mental illness for pharmacists, pharmacy technicians, and PharmD candidates.